Lieke C E Noij
Overview
Explore the profile of Lieke C E Noij including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Slob E, Vijverberg S, Ruffles T, Noij L, Biermann J, Brouwer A, et al.
Allergy
. 2024 Dec;
PMID: 39723595
Background: Long-acting beta2-agonists (LABA) in combination with inhaled corticosteroids (ICS) are commonly used to treat asthma, however, some children lack response to the addition of LABA. This might be partially...
2.
Lap C, Brackel C, Winkel A, Hashimoto S, Haverkort M, Noij L, et al.
Pediatr Res
. 2024 Sep;
PMID: 39333387
Background: To determine the prevalence of pediatric Post-COVID-19 condition (PPCC), identify risk factors, and assess the quality of life in children with differing severities of acute COVID-19. Methods: During a...
3.
Noij L, Blankestijn J, Lap C, van Houten M, Biesbroek G, der Zee A, et al.
World J Pediatr
. 2024 Jul;
PMID: 38954138
No abstract available.
4.
Blankestijn J, Baalbaki N, Bazdar S, Beekers I, Beijers R, van den Bergh J, et al.
J Allergy Clin Immunol
. 2024 Jun;
154(3):807-818.
PMID: 38830512
Background: Months after infection with severe acute respiratory syndrome coronavirus 2, at least 10% of patients still experience complaints. Long-COVID (coronavirus disease 2019) is a heterogeneous disease, and clustering efforts...
5.
Noij L, Blankestijn J, Lap C, van Houten M, Biesbroek G, der Zee A, et al.
World J Pediatr
. 2024 Apr;
20(7):682-691.
PMID: 38664324
Background: Pediatric post coronavirus disease 2019 (COVID-19) condition (PPCC) is a heterogeneous syndrome, which can significantly affect the daily lives of children. This study aimed to identify clinically meaningful phenotypes...
6.
Blankestijn J, I Abdel-Aziz M, Baalbaki N, Bazdar S, Beekers I, Beijers R, et al.
BMJ Open Respir Res
. 2024 Apr;
11(1).
PMID: 38663887
Background: Four months after SARS-CoV-2 infection, 22%-50% of COVID-19 patients still experience complaints. Long COVID is a heterogeneous disease and finding subtypes could aid in optimising and developing treatment for...
7.
Cornelissen M, Bloemsma L, Vaes A, Baalbaki N, Deng Q, Beijers R, et al.
J Transl Med
. 2024 Feb;
22(1):191.
PMID: 38383493
Background: In the Netherlands, the prevalence of post COVID-19 condition is estimated at 12.7% at 90-150 days after SARS-CoV-2 infection. This study aimed to determine the occurrence of fatigue and...
8.
Brackel C, Noij L, Vijverberg S, Legghe C, Maitland-van der Zee A, van Goudoever J, et al.
Pediatr Res
. 2024 Jan;
96(2):319-324.
PMID: 38287106
Background: Pediatric Post-COVID-Condition (PPCC) clinics treat children despite limited scientific substantiation. By exploring real-life management of children diagnosed with PPCC, the International Post-COVID-Condition in Children Collaboration (IP4C) aimed to provide...